Clinical trial Recruiting at 1 site Interventional Ages 1 Month to 18

Probiotics to Prevent Pneumonia in Critically Ill Kids in the PICU

Official title: Assessment of Probiotic Role in Prevention of Ventilator Associated Pneumonia in Critically- Ill Children Admitted at Pediatric Intensive Care Unit

Run by Tanta University · NCT07848165 · Data updated 2026-11-12

We’re testing whether giving probiotics to critically ill children on a ventilator helps prevent ventilator-associated pneumonia.

More Ventilator Associated Pneumonia trials

Quick facts

Study typeInterventional
Ages1 Month to 18 Years
SexAll
Enrollment68 (estimated)
SponsorTanta University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Tanta, Al Gharbia)
StatusRecruiting
StartedJuly 1, 2026
Main results expectedFebruary 1, 2027
Study endsFebruary 1, 2027
Registry record updatedSeptember 29, 2026
Trial IDNCT07848165 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are critically ill children aged 1 month to 18 years who are on mechanical ventilation and not ventilated for a chest infection.

Probably not a fit

Patients who do not respond to probiotic therapy or who have conditions that contraindicate enteral feeding may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial will assess whether probiotic supplementation, in addition to standard care, reduces the incidence of ventilator-associated pneumonia among children aged 1 month to 18 years who are critically ill and on mechanical ventilation in the pediatric intensive care unit at Tanta University Hospitals. The study will compare probiotic use with standard management to see if gut bacteria influence infection risk. Early- vs. late-onset VAP will be considered, with awareness of potential antibiotic-resistant pathogens in longer ICU stays. Exclusion criteria include recent enteral vaccines, significant immunosuppression, feeding contraindications, and certain gastrointestinal conditions.

Why it matters

Potential benefit: If successful, probiotics could lower the risk of VAP and shorten ventilation and ICU stay for some children.

How similar studies have gone: Previous studies in other populations suggest probiotics can reduce respiratory infections, but results in critically ill children are variable and further validation is needed.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Critically ill children from 1 month to 18 years.
* Both sexes.
* Ventilated not due to chest infection.

Exclusion Criteria:

* Children recently received enteral vaccines.
* Children receiving chronic immunosuppressive such as chemotherapy agents. and immunosuppressive medications, and high dose corticosteroids (more than 1 milligram per kilogram).
* Children with contraindications of enteral feeding.
* Children with gastrointestinal bleeding.
* Children with open wounds following major surgery.
* Children with short gut syndrome.

Where it's running

  • Tanta University
    Tanta, Al Gharbia, Egypt
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.